Morbid obesity in total hip arthroplasty: What does it mean?

Jose A. Romero, Richard Jones, Timothy S. Brown, Sean N. Shahrestani, Michael H. Huo

Research output: Contribution to journalArticle

Abstract

Obesity affects 34% of the U.S. population, and the number of obese patients undergoing elective total hip arthroplasty (THA) is increasing each year. The objective of this study is to summarize the current scientific findings regarding the outcomes of THA in the morbidly obese (BMI > 40kg/m2) patients. Specifically, our goal is to identify the incidence of complications and the influence on clinical and functional outcome measures in morbidly obese patients undergoing elective primary THA. A systematic review was performed identifying all of the studies from the PubMed, Medline, EBSCO and Cochrane Library databases that reported outcomes of primary THA in morbidly obese [body mass index (BMI) ≥ 40kg/m2] patients. We identified 13 articles that met inclusion criteria for systematic review. These studies included 15,906 primary THAs in morbidly obese patients. Morbidly obese patients underwent THA at a significantly younger age compared to the non-morbidly obese cohort (63 years versus 70 years) comparator group. Eleven of the 13 studies reported complication rates in morbidly obese versus non-obese patient cohorts. Eight of the 11 studies reported increased complication rates in morbidly obese patients. Of the 13 studies, 9 had documented outcome scores in morbidly obese patients. All studies concluded that morbidly obese patients had the poorest overall preoperative and postoperative functional scores. Seven of the studies also documented the net gain in functional scores after THA between the morbidly obese and the non-morbidly obese groups. No difference was found between the groups. Morbidly obese patients undergo primary THA at a significantly younger age than non-obese patients. Furthermore, morbidly obese patients have a higher perioperative complication rate. Overall outcome measures are worse in the pre-operative and the post-operative phase in the short- and the medium-term follow-up time intervals. However, morbidly obese patients have similar functional gains as non-morbidly obese patients following THA.

Original languageEnglish (US)
JournalSeminars in Arthroplasty
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Morbid Obesity
Arthroplasty
Hip
Body Mass Index
Outcome Assessment (Health Care)
Tacrine
PubMed
Libraries

Keywords

  • BMI
  • Body Mass Index
  • Hip Arthroplasty
  • Morbid Obesity
  • Obese
  • Obesity
  • THA
  • Total Hip

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Morbid obesity in total hip arthroplasty : What does it mean? / Romero, Jose A.; Jones, Richard; Brown, Timothy S.; Shahrestani, Sean N.; Huo, Michael H.

In: Seminars in Arthroplasty, 01.01.2018.

Research output: Contribution to journalArticle

Romero, Jose A. ; Jones, Richard ; Brown, Timothy S. ; Shahrestani, Sean N. ; Huo, Michael H. / Morbid obesity in total hip arthroplasty : What does it mean?. In: Seminars in Arthroplasty. 2018.
@article{e61349c903a645b3adaeae4a6ca70884,
title = "Morbid obesity in total hip arthroplasty: What does it mean?",
abstract = "Obesity affects 34{\%} of the U.S. population, and the number of obese patients undergoing elective total hip arthroplasty (THA) is increasing each year. The objective of this study is to summarize the current scientific findings regarding the outcomes of THA in the morbidly obese (BMI > 40kg/m2) patients. Specifically, our goal is to identify the incidence of complications and the influence on clinical and functional outcome measures in morbidly obese patients undergoing elective primary THA. A systematic review was performed identifying all of the studies from the PubMed, Medline, EBSCO and Cochrane Library databases that reported outcomes of primary THA in morbidly obese [body mass index (BMI) ≥ 40kg/m2] patients. We identified 13 articles that met inclusion criteria for systematic review. These studies included 15,906 primary THAs in morbidly obese patients. Morbidly obese patients underwent THA at a significantly younger age compared to the non-morbidly obese cohort (63 years versus 70 years) comparator group. Eleven of the 13 studies reported complication rates in morbidly obese versus non-obese patient cohorts. Eight of the 11 studies reported increased complication rates in morbidly obese patients. Of the 13 studies, 9 had documented outcome scores in morbidly obese patients. All studies concluded that morbidly obese patients had the poorest overall preoperative and postoperative functional scores. Seven of the studies also documented the net gain in functional scores after THA between the morbidly obese and the non-morbidly obese groups. No difference was found between the groups. Morbidly obese patients undergo primary THA at a significantly younger age than non-obese patients. Furthermore, morbidly obese patients have a higher perioperative complication rate. Overall outcome measures are worse in the pre-operative and the post-operative phase in the short- and the medium-term follow-up time intervals. However, morbidly obese patients have similar functional gains as non-morbidly obese patients following THA.",
keywords = "BMI, Body Mass Index, Hip Arthroplasty, Morbid Obesity, Obese, Obesity, THA, Total Hip",
author = "Romero, {Jose A.} and Richard Jones and Brown, {Timothy S.} and Shahrestani, {Sean N.} and Huo, {Michael H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1053/j.sart.2018.02.013",
language = "English (US)",
journal = "Seminars in Arthroplasty",
issn = "1045-4527",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Morbid obesity in total hip arthroplasty

T2 - What does it mean?

AU - Romero, Jose A.

AU - Jones, Richard

AU - Brown, Timothy S.

AU - Shahrestani, Sean N.

AU - Huo, Michael H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Obesity affects 34% of the U.S. population, and the number of obese patients undergoing elective total hip arthroplasty (THA) is increasing each year. The objective of this study is to summarize the current scientific findings regarding the outcomes of THA in the morbidly obese (BMI > 40kg/m2) patients. Specifically, our goal is to identify the incidence of complications and the influence on clinical and functional outcome measures in morbidly obese patients undergoing elective primary THA. A systematic review was performed identifying all of the studies from the PubMed, Medline, EBSCO and Cochrane Library databases that reported outcomes of primary THA in morbidly obese [body mass index (BMI) ≥ 40kg/m2] patients. We identified 13 articles that met inclusion criteria for systematic review. These studies included 15,906 primary THAs in morbidly obese patients. Morbidly obese patients underwent THA at a significantly younger age compared to the non-morbidly obese cohort (63 years versus 70 years) comparator group. Eleven of the 13 studies reported complication rates in morbidly obese versus non-obese patient cohorts. Eight of the 11 studies reported increased complication rates in morbidly obese patients. Of the 13 studies, 9 had documented outcome scores in morbidly obese patients. All studies concluded that morbidly obese patients had the poorest overall preoperative and postoperative functional scores. Seven of the studies also documented the net gain in functional scores after THA between the morbidly obese and the non-morbidly obese groups. No difference was found between the groups. Morbidly obese patients undergo primary THA at a significantly younger age than non-obese patients. Furthermore, morbidly obese patients have a higher perioperative complication rate. Overall outcome measures are worse in the pre-operative and the post-operative phase in the short- and the medium-term follow-up time intervals. However, morbidly obese patients have similar functional gains as non-morbidly obese patients following THA.

AB - Obesity affects 34% of the U.S. population, and the number of obese patients undergoing elective total hip arthroplasty (THA) is increasing each year. The objective of this study is to summarize the current scientific findings regarding the outcomes of THA in the morbidly obese (BMI > 40kg/m2) patients. Specifically, our goal is to identify the incidence of complications and the influence on clinical and functional outcome measures in morbidly obese patients undergoing elective primary THA. A systematic review was performed identifying all of the studies from the PubMed, Medline, EBSCO and Cochrane Library databases that reported outcomes of primary THA in morbidly obese [body mass index (BMI) ≥ 40kg/m2] patients. We identified 13 articles that met inclusion criteria for systematic review. These studies included 15,906 primary THAs in morbidly obese patients. Morbidly obese patients underwent THA at a significantly younger age compared to the non-morbidly obese cohort (63 years versus 70 years) comparator group. Eleven of the 13 studies reported complication rates in morbidly obese versus non-obese patient cohorts. Eight of the 11 studies reported increased complication rates in morbidly obese patients. Of the 13 studies, 9 had documented outcome scores in morbidly obese patients. All studies concluded that morbidly obese patients had the poorest overall preoperative and postoperative functional scores. Seven of the studies also documented the net gain in functional scores after THA between the morbidly obese and the non-morbidly obese groups. No difference was found between the groups. Morbidly obese patients undergo primary THA at a significantly younger age than non-obese patients. Furthermore, morbidly obese patients have a higher perioperative complication rate. Overall outcome measures are worse in the pre-operative and the post-operative phase in the short- and the medium-term follow-up time intervals. However, morbidly obese patients have similar functional gains as non-morbidly obese patients following THA.

KW - BMI

KW - Body Mass Index

KW - Hip Arthroplasty

KW - Morbid Obesity

KW - Obese

KW - Obesity

KW - THA

KW - Total Hip

UR - http://www.scopus.com/inward/record.url?scp=85043329942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043329942&partnerID=8YFLogxK

U2 - 10.1053/j.sart.2018.02.013

DO - 10.1053/j.sart.2018.02.013

M3 - Article

AN - SCOPUS:85043329942

JO - Seminars in Arthroplasty

JF - Seminars in Arthroplasty

SN - 1045-4527

ER -